1Mc Neill MD, Lawrence D, Wagman MD, et al. Small bowel metastases from primary carcinoma of the lung [ J ]. Cancer, 1987 ,59 : 1486 - 1489.
2Berger A, Cellier C, Daniel C, et al. Small bowel metastases from primary carcinoma of the lung: clinical findings and outcome [ J ]. Am J Gastroenterol, 1999 ,94(7) :1884 - 1887.
3Garwood RA, Sawyer MD, Ledesma EJ, et al. A case and review of bowel perforation secondary to metastatic lung cancer[J]. Am Surg, 2005 ,71 (2) :110 - 116.
4Hecht JL, Pinkus JL, Weinstein LJ, et al. The value of TYF-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin[J]. Am I Clin Pathol,2001,116(4) :483 - 488.
5Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical maker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B [ J].Histopathology, 2000,36( 1 ) : 8 - 16.
6Myong NH. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relation ship with expressions of p53 and Ki-67 proteins[J]. J Korean Med Sci,2003,18(4) :494 - 500.
7Travis WD, Colby, Corrin B, et al. WHO histological typing of lung and pleural tumors[ M ]. 3rd ed. Berlin : Springer, 1995.35.
8Moran CA,Suster S. Tumors of the lung and pleura[ A]. In:Fletcher CDM ed. Diagnostic histopathology of tumors [ M ]. 2nd ed. Londen :Churchill, Livingstone, 2000.171 - 208.
9Ordonez NG. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma[ J]. Am J Surg Pathol,2003,27(8) : 1031 - 1051.
10Abutaily AS, Addis BJ, Roche WR. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies [ J]. J Clin Pathol,2002,55(9) :662- 668.
